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Summary
Objectives: To determine the surgical-site infection (SSI) incidence rate targeted on salivary
gland surgery over a 2-year period (from January 2007 to December 2008). Then identify any
risk factors associated with SSI in all the patients operated with no antibiotic prophylaxis in
accordance with French Anesthesiology Society guidelines.
Population and methods: Ninety-three patients were operated during the standard SSI surveil-
lance period. A case-control (one case for ﬁve controls) study was then conducted aiming to
identify risk factors.
Results: The SSI incidence rate was 9.7%. The case-control study failed to identify any relevant
risk factor with univariate analysis.
Conclusion: As no risk factors could be identiﬁed, we suggest that surgical antibioprophylaxis
could be relevant in salivary glands surgery and should be evaluated in this setting.
© 2010 Published by Elsevier Masson SAS.
tntroductionithin the surgical-site infection (SSI) monitoring program
roposed by the Nosocomial Infection Alert, Investigation,
nd Monitoring French Network and the Professional Prac-
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oi:10.1016/j.anorl.2010.02.001ices Assessment Program (Réseau d’alerte, d’investigation
t de surveillance des infections nosocomiales; RAISIN)
eﬁned at the Toulouse University Hospital, the ENT sur-
ical team opted for targeted monitoring of salivary gland
urgery.
Today’s RAISIN database has no French data speciﬁc to
his type of surgery, with the head and neck incidence
ate at 0.7% for head and neck surgeries on noncancer-
us lesions and 7.5% for cervicofacial oncology surgeries,
ncluding the pharynx/larynx and trachea [1]. The rare data
ound in the literature report SSI rates varying from 0 to
%.
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(Surgical-site infections and surgery of the salivary glands
The objective of this study was ﬁrst to assess the inci-
dence of SSIs after salivary gland surgery and then in a
second phase to search for possible risk factors associated
with SSIs.
We report the results of each of these two phases.
Population and methods
Monitoring surgical-site infection
The methodology and the data collection materials were
designed by RAISIN [2]; the study’s objective was to include
100 consecutive patients. The intraoperative data (type of
surgery, contamination class, American Society of Anesthesi-
ologists [ASA] score, and duration of surgery [from incision to
closure, in minutes]) were collected in the operating room;
the follow-up (presence of a SSI and if so its characteris-
tics, date of last contact) was carried out by the referring
surgeon in liaison with colleagues. A SSI is an infection occur-
ring within 30 days following the intervention [2]. The SSI
diagnostic criteria retained in the study were essentially the
presence of signs of local infection such as pain, redness,
heat, purulent discharge with or without collection, some-
times associated with general signs such as fever. Bacterial
samples were not collected systematically, but they are not
indispensable to conﬁrm a SSI. Exhaustivity was veriﬁed by
comparison with operative lists of the corresponding period.
Inclusion in the study began on 15 January 2007 and ended
on 31st December 2008, with the objective of including 100
interventions.
Data entry and analysis were carried out using EPIINFO
software made available by RAISIN. In absence of speciﬁc
references for salivary gland surgery, the National Noso-
comial Infection Surveillance (NNIS) score was calculated
taking the 75th percentile as the surgery duration param-
eter, as found in the longitudinal monitoring database.
For practical reasons, inclusions were stopped on
31st December 2008, in agreement with the surgical team.
Possible risk factors were then sought through a case-control
analysis.
Case-control study
In the database established throughout the longitudinal
monitoring process, the controls were randomly selected,
with a maximum of ﬁve controls for every case.
A data collection tool was elaborated speciﬁcally to
record the following information:
• the usual criteria: age, sex, date of surgery, duration
of surgery, ASA anesthetic score, and contamination
class;
• speciﬁc data on the patient (initial disease based on
the pathology, examination of the excised specimen,
associated pathologies such as diabetes, medications
modifying hemostasis, a history of radio- or chemother-
apy), data on the surgical intervention (surgeon,
type of surgery [submaxillectomy, partial parotidec-
tomy, total parotidectomy, ligature of the salivary
canal, existence or absence of hematoma]), place of
preoperative cutaneous debridement (unit or operat-
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ing room) and the product used, need for surgical
revision the same day as the intervention, presence
of bleeding and/or inﬂammation, and presence of
edema;
the NNIS score calculated based on three parameters: the
ASA score, the contamination class, and the duration of
the intervention.
The statistical analysis was done using STATA 9.2 SE soft-
are. We conducted a bivariate analysis between the
onfounding factors and the dependent variables and the
ndpoint (the presence of a SSI). The confounding fac-
ors chosen were age, sex, and diabetes and correspond
o patient characteristics. These confounding factors are
actors that, although not directly inﬂuential factors, have
probable inﬂuence that can lead to confounding bias.
he factors studied were initial disease, taking medications
odifying hemostasis, history of radio- or chemotherapy,
he NNIS score, and the factors relative to the surgical inter-
ention. The means of the quantitative variables (age and
uration of surgery) were compared using the Student t-
est or a Wilcoxon’s nonparametric test; the distributions
f the qualitative variables were compared using the Chi2
est or the Fisher’s exact test. A multivariate analysis (logis-
ic regression) was planned taking into account the factors
ssociated with the onset of a SSI with signiﬁcance set at
< 0.25 in bivariate analysis.
esults
ongitudinal study
n 31st December 2008, 93 interventions on the salivary
lands had been included, with 42 interventions in 2007 and
1 interventions in 2008.
The patients’ mean age was 56± 18 years, the sex ratio
as 1.7:
27% of the patients were classiﬁed ASA 1;
53% were classiﬁed ASA 2;
20% were classiﬁed ASA 3.
The 75th percentile was deﬁned at 123min. The NNIS
core was distributed as follows:
34%, NNIS 0;
49%, NNIS 1;
15%, NNIS 2;
2%, NNIS 3.
Seventy-seven interventions involved the parotids and
6 the submandibular glands. Twenty-four interventions fol-
owed cancer, 34 pleomorphous adenoma, 23 another benign
umor, and 12 lithiasis.
Nine SSIs occurred, leading to an overall SSI rate of 9.7%
95% conﬁdence interval [95%CI]: 4.5; 17.6); this rate was
% (95%CI: 3.7; 17.8) for parotid surgery and 13% (95%CI:
.6; 38.3) for submandibular gland surgery.
The mean time to SSI was 26± 34 days. Of the nine SSIs,
ve (55.6%) occurred within 8 days, two between 8 and
0 days, and two later; the latter two were nonetheless
4Table 1 Bivariate analysis according to confounding
factors.
Controls (n = 47) Cases (n = 9) Pa
n % n %
Age (years)
18—54 18 38.3 1 11.1 0.097
55—66 13 27.7 6 66.7
67—85 16 34.0 2 22.2
Sex
Male 30 63.8 7 77.8 0.70
Female 17 36.2 2 22.2
r
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tDiabetes 4 8.5 1 11.1 1.00
a Fisher’s exact test.
etained because they were authenticated by the surgeons
excluding them, the overall SSI rate would be 7.5% [95%CI:
.1; 14.9]). Five SSIs required surgical revision. From the
acteriological point of view, Staphylococcus aureus was
ound in two cases, Streptococcus intermedius in one case,
treptococcus milleri in one case, and Corynebacterium
pp. in one case; the four remaining cases had no micro-
iological documentation.
earch for risk factors
ine infected patients were compared to 47 randomly
elected noninfected controls (1:5 controls).
Fifty-six patients were studied: 66% males and 34%
emales. In the infected patients, the mean age was
0.9± 10.3 years and in the controls the mean age was
7.7± 17.1 years (range: 18—85 years). The mean dura-
ion of surgery was 159.8± 84.4min for the cases and
65.6± 98.7min for the controls.
None of the 56 patients had preoperative antibiotic treat-
ent.
onfounding factors
f the possible confounding factors, there was no signiﬁ-
ant difference between the cases and the controls for mean
ge (60.9 years vs. 57.7 years; P = 0.94) or presence of dia-
etes. The bivariate analysis of the confounding factors is
resented in Table 1.
he dependent variables
f the dependent variables, an inﬂammatory syndrome
nd the presence of a hematoma or an edema were more
requently found in the infected patients. All the other
ependent variables did not show a signiﬁcant difference
etween cases and controls. The bivariate analysis of the
actors studied is presented in Table 2.
After adjustment for age, the probability of SSI onset
as more frequent in presence of edema/hematoma or
n inﬂammatory syndrome, with odds ratios (OR) of 11.6
95%CI: 1.8; 72.3) and 20.4 (95%CI: 2.0; 219.9), respec-
ively. These measures were not adjusted for the NNIS score
r the contamination class because of the imbalance in the
istribution of these two variables.
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iscussion
alivary gland surgery is rarely individualized within head
nd neck surgeries in the databases constructed based on
he required monitoring data; it accounts for only a small
art of the activity in our unit and therefore a long inclusion
eriod was used in the study, although this did not solve the
tudy’s problems of statistical power.
The overall SSI rate, 9.7%, would have been 7.5% if two of
he SSIs had been excluded because of delayed onset longer
han 30 days for surgery that did not involve implantation
f foreign material, which placed the SSI rate in this study
t the upper limit of the rates reported in the literature,
—7% [3,4] for varied head and neck surgeries. More specif-
cally for salivary gland surgery, two retrospective studies
re interesting. One reports 325 interventions and found
0.9% infection rate for parotidectomies and 1% for sub-
andibulectomies [5]; however, nearly one-fourth of the
atients received antibiotics in the perioperative period.
he other, covering a period of 11 years, on parotid and
enign tumor surgery, reported a 7% infection rate [6] and
dentiﬁcation of three independent risk factors: ligature of
he salivary canal, total ablation of the parotid gland, and
atient age greater than 60 years, factors that we were not
ble to identify, perhaps because of insufﬁcient statistical
ower in our study.
Malignant tumors account for approximately 8—18% of
alivary gland tumors [7]. Of the benign tumors, pleomor-
hous adenomas account for more than 50% of the parotid
umors and are observed at all ages, with a maximum fre-
uency between 30 and 60 years, with no predominance
f either sex; cystadenolymphomas, or Warthin’s tumors,
ccount for 5—10% of the parotid tumors [7]. Parotid tumors
ccount for 90% of the salivary gland tumors [8].
Salivary lithiases are frequent ailments; submandibular
ithiasis is by far the most often encountered and is observed
t all ages. It very frequently presents infectious signs [7].
herefore, submandibulectomies are infected more often
han parotidectomies.
Previous chemotherapy is also a risk factor for postoper-
tive infection [9—11].
The contamination class (clean for parotidectomies and
lean-contaminated for submandibulectomies), the dura-
ion of surgery, and the ASA score are independent risk
actors of SSI onset, grouped in a NNIS score that is highly
redictive of SSI [12]. In our study, the NNIS score did not dif-
er between infected and noninfected patients, with most
atients in the NNIS 0 category, an even stronger indication
iven that 75th percentile value was calculated on the pop-
lation of cases and controls, making this parameter less
iscriminatory. The only factors that we observed to be sig-
iﬁcantly associated with infection were the presence of
n inﬂammatory syndrome and the presence of hematoma
r edema. These two factors are highly related and ﬁnally
nly announce infection, since the conditions for infection to
evelop are undoubtedly already present: should they lead
o implementing probabilistic curative antibiotic therapy?Hematoma and edema are associated with SSI; how-
ver, they are noted after the intervention and are more a
ymptom of the infectious complication of the surgical site
han an associated risk factor and also have no predictive
alue.
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Table 2 Bivariate analysis according to dependent factors.
Controls Cases Pa
n N % n N %
Disease
Cancer 8 47 17.0 2 9 22.2 0.78
Pleomorphous adenoma 17 47 36.2 2 9 22.2
Benign tumor 15 47 31.9 3 9 33.3
Lithiasis 7 47 14.9 2 9 22.2
Experienced operator 31 47 66.0 5 9 55.6 0.71
Debridement in operating room 5 47 9.6 1 9 11.1 1.00
Type of surgery
SM 9 47 19.1 2 9 22.2 1.00
PP 9 47 19.1 2 9 22.2
PT 29 47 61.7 5 9 55.6
Side of surgery
Right 25 44b 56.8 4 8 50.0 1.00
Left 19 44b 43.2 4 8 50.0
Class of contamination
1 45 47 95.7 8 9 88.9 0.18
2 2 47 4.3 0 9 0.0
3 0 47 0.0 1 9 11.1
4 0 47 0.0 0 9 0.0
NNIS score
0 19 47 40.4 4 9 44.4 0.20
1 20 47 42.6 4 9 44.4
2 8 47 17.0 0 9 0.0
3 0 47 0.0 1 9 11.1
Salivary canal ligature 5 47 10.6 1 9 11.1 1.00
Hematoma/edema 6 47 12.8 5 9 55.6 0.01
Any change in hemostasis 10 47 21.3 3 9 33.3 0.42
Bleeding 6 47 12.8 2 9 22.2 0.60
Inﬂammatory syndrome 7 47 14.9 5 9 55.6 0.02
N m± N m± Pc
Duration of intervention (min) 47 165.6 ± 98.7 9 159.8 ± 84.4 0.97
SM: submaxillectomy; PP: partial parotidectomy; PT: total parotidectomy; NNIS: National Nosocomial Infection Surveillance; ttt: treat-
ment.
a Fisher’s exact test.
b
t
f
t
a
sb For three patients, the side of surgery was unknown
c Wilcoxon’s test.
With the exception of advancing the indications for pre-
operative antibiotic prophylaxis [13], our study did not
provide the means for improving preventive strategies. How-
ever, the awareness campaign at the beginning of 2008
aimed at the surgical team through the dissemination of
the results for 2007 had a positive effect (six out of 43 SSI
patients in 2007, three out of 50 in 2008) [14].Conclusion
This study found the SSI incidence rate following salivary
gland surgery close to the rates reported in the literature
C
Tut did not identify particular risk factors. The lack of statis-
ical power stemming from the small numbers of infections
ound could easily be resolved in a multicenter study. Finally,
his study raises the question of the beneﬁt of preoperative
ntibiotic prophylaxis in this type of surgery, particularly in
ubmandibulectomies for lithiasis.onﬂict of interest statement
he authors have not communicated conﬂicts of interest.
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